BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2552343)

  • 1. Regulation of vasopressin receptors and phosphoinositide hydrolysis in the septum of heterozygous and homozygous Brattleboro rats.
    Shewey LM; Boer GJ; Szot P; Dorsa DM
    Neuroendocrinology; 1989 Sep; 50(3):292-8. PubMed ID: 2552343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced phosphoinositol hydrolysis in response to vasopressin in the septum of the homozygous Brattleboro rat.
    Shewey LM; Brot MD; Szot P; Dorsa DM
    Brain Res; 1989 Jan; 478(1):95-102. PubMed ID: 2924125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced binding of 3H-arginine8-vasopressin in the Brattleboro rat.
    Shewey LM; Dorsa DM
    Peptides; 1986; 7(4):701-4. PubMed ID: 3763443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V1-type vasopressin receptors in rat brain septum: binding characteristics and effects on inositol phospholipid metabolism.
    Shewey LM; Dorsa DM
    J Neurosci; 1988 May; 8(5):1671-7. PubMed ID: 2835449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vasopressin administration and deficiency upon 3H-AVP binding sites in the CNS and periphery during development.
    Szot P; Myers KM; Dorsa DM
    Peptides; 1992; 13(2):389-94. PubMed ID: 1409016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine vasopressin as an intragonadal hormone in Brattleboro rats: presence of a testicular vasopressin-like peptide and functional vasopressin receptors.
    Kasson BG; Hsueh AJ
    Endocrinology; 1986 Jan; 118(1):23-31. PubMed ID: 3000735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
    Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
    Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats.
    Antoni FA; Holmes MC; Kiss JZ
    Endocrinology; 1985 Oct; 117(4):1293-9. PubMed ID: 3161722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.
    Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA
    Synapse; 1988; 2(3):205-11. PubMed ID: 2975069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of V2 receptors in renal medulla of homozygous Brattleboro rats by arginine vasopressin.
    Cornett LE; Breckinridge SM; Koike TI
    Peptides; 1989; 10(5):985-91. PubMed ID: 2558368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific receptors for vasopressin in the pituitary gland: evidence for down-regulation and desensitization to adrenocorticotropin-releasing factors.
    Koch B; Lutz-Bucher B
    Endocrinology; 1985 Feb; 116(2):671-6. PubMed ID: 2981673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with vasopressin analogues alters affinity of vasopressin receptors in the septum and amygdala of the rat brain.
    Swank MW; Dorsa DM
    Brain Res; 1991 Mar; 544(2):342-4. PubMed ID: 1828186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a specific, high affinity [3H]arginine8 vasopressin-binding site on liver microsomes from different strains of rat and the role of magnesium.
    Gopalakrishnan V; Triggle CR; Sulakhe PV; McNeill JR
    Endocrinology; 1986 Mar; 118(3):990-7. PubMed ID: 3004905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system control of pituitary vasopressin receptors: evidence for involvement of multiple factors.
    Lutz-Bucher B; Kovacs K; Makara G; Stark E; Koch B
    Neuroendocrinology; 1986; 43(5):618-24. PubMed ID: 3018613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine-vasopressin binding to isolated hippocampal microvessels of rats with different endogenous concentrations of the neuropeptide.
    Kretzschmar R; Ermisch A
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):151-6. PubMed ID: 2599015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contractile effect and tissue content of arginine vasopressin in the urinary bladder of Brattleboro rats with hereditary diabetes insipidus.
    Uvelius B; Lundin S; Andersson KE
    Gen Pharmacol; 1992 Jul; 23(4):591-4. PubMed ID: 1397966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central vasopressin pretreatment sensitizes phosphoinositol hydrolysis in the rat septum.
    Lebrun CJ; Gruber MG; Meister M; Unger T
    Brain Res; 1990 Oct; 531(1-2):167-72. PubMed ID: 1963099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of protein kinase C in the coupling between the V1 vasopressin receptor and phospholipase C in rat glomerulosa cells: effects on aldosterone secretion.
    Gallo-Payet N; Chouinard L; Balestre MN; Guillon G
    Endocrinology; 1991 Aug; 129(2):623-34. PubMed ID: 1830269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells.
    Gopalakrishnan V; Xu YJ; Sulakhe PV; Triggle CR; McNeill JR
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1927-36. PubMed ID: 1836312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.